Learn More
Medchemexpress LLC VQW-765 | 669770-29-0 | MFCD28502153 | 99.6% | 294.39 g/mol | C19H22N2O | 10 MG

Supplier: Medchemexpress LLC HY1949010MG
VQW-765 is an orally active, selective partial agonist of the α7 nicotinic acetylcholine receptor (α7-nAChR) developed for preclinical research into anxiety and related CNS disorders. Supplied as a pre-weighed 10 mg research reagent, it is intended for use in in vitro and in vivo studies and is not for human consumption.
- Selective α7 nicotinic acetylcholine receptor partial agonist.
- Orally active compound suitable for in vivo dosing.
- High chemical purity (approximately 99.6%).
- Supplied as a pre-weighed 10 mg quantity for dosing convenience.
- Appropriate for both in vitro and in vivo pharmacology studies.
- Research use only; not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.